E.O. Oloo
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Molecular Medicine top 10%
Papers in
-
- Protein Structure and Dynamics 3
- RNA and protein synthesis mechanisms 3
- Natural product bioactivities and synthesis 2
-
- Synthesis and biological activity 6
- Co-authors
- D. Peter Tieleman (5 shared papers)Jonathan R. Dimmock (7 shared papers)J. Wilson Quail (7 shared papers)Theresa M. Allen (5 shared papers)Erik De Clercq (5 shared papers)Gordon A. Zello (4 shared papers)C.L. Santos (4 shared papers)Heinz‐Bernhard Kraatz (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (3 papers)Journal of Biological Chemistry (3 papers)Journal of Medicinal Chemistry (2 papers)PLoS ONE (2 papers)Biochemistry and Cell Biology (1 paper)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
E.O. Oloo
18 papers receiving 799 citations
Peers
Comparison fields: 5 of 76
- Toxicology 50
- Molecular Medicine 58
- Organic Chemistry 321
- Molecular Biology 439
- Oncology 150
Countries citing papers authored by E.O. Oloo
This map shows the geographic impact of E.O. Oloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.O. Oloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.O. Oloo more than expected).
Fields of papers citing papers by E.O. Oloo
This network shows the impact of papers produced by E.O. Oloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.O. Oloo. The network helps show where E.O. Oloo may publish in the future.
Co-authors
The 25 scholars most cited alongside E.O. Oloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 193 | |
| 2 | 2001 | 185 | |
| 3 | 2002 | 83 | |
| 4 | 2004 | 78 | |
| 5 | 2000 | 62 | |
| 6 | 2006 | 48 | |
| 7 | 2002 | 36 | |
| 8 | 2018 | 36 | |
| 9 | 2011 | 27 | |
| 10 | 2002 | 18 | |
| 11 | 2021 | 17 | |
| 12 | 2006 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2018 | 5 | |
| 15 | 2007 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2002 | 1 | |
| 19 | 2002 | 0 |
About E.O. Oloo
E.O. Oloo is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Oncology and Toxicology, having authored 19 papers that have together received 816 indexed citations. Recurring topics across this work include Synthesis and biological activity (6 papers), Synthesis of Organic Compounds (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Protein Structure and Dynamics (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), RNA and protein synthesis mechanisms (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Toxicology (50 citations), Molecular Medicine (58 citations), Organic Chemistry (321 citations), Molecular Biology (439 citations) and Oncology (150 citations). E.O. Oloo has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include D. Peter Tieleman, Jonathan R. Dimmock, J. Wilson Quail, Theresa M. Allen, Erik De Clercq, Gordon A. Zello, C.L. Santos, Heinz‐Bernhard Kraatz, Jan Balzarini and Adil J. Nazarali. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Biological Chemistry, Journal of Medicinal Chemistry, PLoS ONE and Biochemistry and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.